Cigarette smoking women of reproductive age who use oral contraceptives: Results from the 2002 and 2004 behavioral risk factor surveillance systems

Women's Health Issues

Volumn 20, Issue 6, 2010, Pages 380-385

  Mcclave, Annette K ^a   Hogue, Carol J ^b   Brunner Huber, Larissa R ^c   Ehrlich, Alexandra C ^d  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^d NORTHROP GRUMMAN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CIGARETTE SMOKING; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG USE; EDUCATION; ETHNICITY; FEMALE; HEALTH CARE; HUMAN; MARRIAGE; ORAL CONTRACEPTION; PREVALENCE; RACE DIFFERENCE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; RISK REDUCTION; SELF REPORT; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CEREBROVASCULAR DISORDERS; CONTRACEPTION; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; LOGISTIC MODELS; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SMOKING; SOCIOECONOMIC FACTORS; UNITED STATES; WOMEN; YOUNG ADULT;

EID: 78049530984     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2010.06.006     Document Type: Article

References (34)

1. American College of Obstetricians and Gynecologists (ACOG) ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstetrics & Gynecology 2006, 107(6):1453-1472.
2. Barrett D.H., Anda R.F., Escobedo L.G., Croft J.B., Williamson D.F., Marks J.S. Trends in oral contraceptive use and cigarette smoking. Behavioral Risk Factor Surveillance System, 1982 and 1988. Archives of Family Medicine 1994, 3(5):438-443.
3. Blumberg S.J., Luke J.V., Cynamon M.L. Telephone coverage and health survey estimates: Evaluating the need for concern about wireless substitution. American Journal of Public Health 2006, 96(5):926-931.
4. Caraballo R.S., Giovino G.A., Pechacek T.F., Mowery P.D. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. American Journal of Epidemiology 2001, 153(8):807-814.
5. Centers for Disease Control and Prevention (CDC) Current trends in cigarette smoking among reproductive-aged Women-Behavioral Risk Factor Surveillance System, 1989. MMWR Morbidity & Mortality Weekly Report 1991, 40(42):719-723.
6. Centers for Disease Control and Prevention (CDC) Cigarette smoking among reproductive-aged women-Behavioral Risk Factor Surveillance System, 1989. MMWR Morbidity & Mortality Weekly Report 1995, 40(42):719-723.
7. Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System: Operational User's Guide 2006, Available:, Accessed May 15, 2006. ftp://ftp.cdc.gov/pub/Data/Brfss/userguide.pdf.
8. Centers for Disease Control and Prevention (CDC) Cigarette smoking among adults-United States, 2007. MMWR Morbidity & Mortality Weekly Report 2008, 57(45):1221-1226.
9. Centers for Disease Control and Prevention (CDC) Smoking prevalence among women of reproductive age-United States, 2006. MMWR Morbidity & Mortality Weekly Report 2008, 57(31):849-852.
10. Coleman L.M., Cater S.M. A qualitative study of the relationship between alcohol consumption and risky sex in adolescents. Archives of Sexual Behavior 2005, 34(6):649-661.
11. Cress R.D., Holly E.A., Ahn D.K., Kristiansen J.J., Aston D.A. Contraceptive use among women smokers and nonsmokers in the San Francisco Bay area. Preventive Medicine 1994, 23(2):181-189.
12. Farley T.M.M., Meirik O., Chang C.L., Marmot M.G., Poulter N.R. Effect of different progestagens in low estrogen oral-contraceptives on venous thromboembolic disease. Lancet 1995, 346(8990):1582-1588.
13. Farley T.M.M., Meirik O., Chang C.L., Poulter N.R. Combined oral contraceptives, smoking, and cardiovascular risk. Journal of Epidemiology & Community Health 1998, 52(12):775-785.
14. Godsland I.F., Winkler U., Lidegaard O., Crook D. Occlusive vascular disorders in oral contraceptive users: Epidemiology, pathology, & mechanisms. Drugs 2000, 60(4):722-869.
15. Goldbaum G.M., Kendrick J.S., Hogelin G.C., Gentry E.M. The relative impact of smoking and oral contraceptive use on women in the United States. Journal of the American Medical Association 1987, 258(10):1339-1342.
16. Hannaford P. Cardiovascular events associated with different combined oral contraceptives: A review of current data. Drug Safety 2000, 22(5):361-371.
17. Hatcher R., Trussell J., Stewart F., Nelson A.L., Cates W., Guest F., et al. Contraceptive Technology 2004, Contraceptive Technology Communications, Inc, New York. 18th ed.
18. Herings R., Urquhart J., Leufkens H. Venous thromboembolism among new users of different oral contraceptives. Lancet 1999, 354:127-128.
19. Keeling D. Combined oral contraceptives and the risk of myocardial infarction. Annals of Medicine 2003, 35:413-418.
20. Lawson D., Davidson J., Jick H. Oral contraceptive use and venous thromboembolism: Absence of an effect of smoking. British Medical Journal 1977, 2:729-730.
21. Link M.W., Battaglia M.P., Frankel M.R., Osborn L., Mokdad A.H. Reaching the US cell phone generation: Comparison of cell phone survey results with an ongoing landline telephone survey. Public Opinion Quarterly 2007, 71(5):814-839.
22. Mosher W.D., Martinez G.M., Chandra A., Abma J.C., Willson S.J. Use of contraception and use of family planning services in the United States: 1982-2002. Advance Data 2004, 350:1-36.
23. Pomp E.R., Rosendaal F.R., Doggen C.J.M. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American Journal of Hematology 2008, 83(2):97-102.
24. Romieu I., Willett W.C., Colditz G.A., Stampfer M.J., Rosner B., Hennekens C.H., et al. Prospective study of oral contraceptive use and risk of breast cancer in women. Journal of the National Cancer Institute 1989, 81(17):1313-1321.
25. Sherif K. Benefits and risks of oral contraceptives. American Journal of Obstetrics & Gynecology 1999, 180(6):S343-S348.
26. Sidney S., Petitti D.B., Soff G.A., Cundiff D.L., Tolan K.K., Quesenberry C.P. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception 2004, 70(1):3-10.
27. Strine T.W., Okoro C.A., Chapman D.P., Balluz L.S., Ford E.S., Ajani U.A., et al. Health-related quality of life and health risk behaviors among smokers. American Journal of Preventive Medicine 2005, 28(2):182-187.
28. Tanis B.C., van den Bosch M.A.A.J., Kemmeren J.M., Cats V.M., Helmerhorst F.M., Algra A., et al. Contraceptives and the risk of myocardial infarction. New England Journal of Medicine 2001, 345(25):1787-1793.
29. U.S.Department of Health and Human Services (USDHHS) Women and smoking: a report of the surgeon general 2001, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
30. U.S.Department of Health and Human Services (USDHHS) The health consequences of smoking: a report of the surgeon general 2004, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
31. Vessey M., Painter R., Yeates D. Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 2003, 362(9379):185-191.
32. World Health Organization (WHO) Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995, 346(8990):1582-1588.
33. World Health Organization (WHO) Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995, 346(8990):1575-1582.
34. Zimlichman E., Mandel D., Mimouni F.B., Wartenfeld R., Huerta M., Grotto I., et al. Oral contraceptive use and smoking habits in young Israeli women: A cross-sectional study. Israel Medical Association Journal 2004, 6(9):546-549.